Overview Performance Dividends Holdings Peer Group Options

(EMSRI) Amundi Index MSCI Emerging - Ratings and Ratios

Exchange: PA • Country: France • Currency: EUR • Type: Etf • ISIN: LU1861138961

EMSRI: Shares, Stocks

Amundi Index MSCI Emerging Markets SRI UCITS (PA:EMSRI) is a France-domiciled ETF listed on Euronext Paris, designed to track the performance of the Morningstar EM TME NR USD index. The fund focuses on global emerging markets equities, employing a passive management strategy to replicate its benchmark. It is structured as an SRI (Socially Responsible Investment) vehicle, integrating environmental, social, and governance (ESG) criteria into its investment process.

As of the latest data, the ETF has an average daily trading volume of 3,711 shares over the past 20 days, with a last price of 48.95. Its short-term technical outlook is neutral, with the SMA-20 at 47.80 and SMA-50 at 50.60, indicating recent price fluctuations around these levels. The SMA-200 stands at 51.86, suggesting the fund is currently trading below its long-term average. The ATR of 1.42 reflects moderate price volatility. The funds assets under management (AUM) total 1.383 billion EUR, indicating a well-established vehicle in its category.

3-Month Forecast: Based on , the ETF may face resistance at its SMA-50 (50.60) and SMA-200 (51.86) levels, potentially capping upside momentum. The ATR of 1.42 suggests moderate price swings, with support likely near the SMA-20 (47.80). indicates a stable AUM base, but emerging market equities could remain sensitive to global macroeconomic conditions, including inflation trends and central bank policies. If these factors stabilize, the fund may recover toward its long-term average; otherwise, it may struggle to break above resistance levels.

Additional Sources for EMSRI ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

EMSRI ETF Overview

Market Cap in USD	1,555m
Category	Global Emerging Markets Equity
TER	0.25%
IPO / Inception	2019-01-16

EMSRI ETF Ratings

Growth Rating	11.6
Fundamental	-
Dividend Rating	0.0
Rel. Strength	-4.62
Analysts	-
Fair Price Momentum	45.93 EUR
Fair Price DCF	-

EMSRI Dividends

Currently no dividends paid

EMSRI Growth Ratios

Growth Correlation 3m	23.4%
Growth Correlation 12m	25.8%
Growth Correlation 5y	-16.5%
CAGR 5y	5.60%
CAGR/Max DD 5y	0.21
Sharpe Ratio 12m	0.77
Alpha	-3.34
Beta	0.602
Volatility	15.06%
Current Volume	7.1k
Average Volume 20d	2.2k

What is the price of EMSRI shares?
As of June 01, 2025, the stock is trading at EUR 52.12 with a total of 7,084 shares traded.
Over the past week, the price has changed by -0.72%, over one month by +6.76%, over three months by -4.62% and over the past year by +8.46%.

Is Amundi Index MSCI Emerging a good stock to buy?
Neither. Based on ValueRay´s Analyses, Amundi Index MSCI Emerging is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 11.57 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of EMSRI is around 45.93 EUR . This means that EMSRI is currently overvalued and has a potential downside of -11.88%.

Is EMSRI a buy, sell or hold?
Amundi Index MSCI Emerging has no consensus analysts rating.

What are the forecasts for EMSRI share price target?
According to our own proprietary Forecast Model, EMSRI Amundi Index MSCI Emerging will be worth about 52 in June 2026. The stock is currently trading at 52.12. This means that the stock has a potential downside of -0.31%.

Issuer	Target	Up/Down from current
Wallstreet Target Price	-	-
Analysts Target Price	-	-
ValueRay Target Price	52	-0.3%